Who is an ACTSI investigator?
Any investigator who received in-kind, indirect, and/or financial support from the NIH-sponsored ACTSI is considered an ACTSI investigator. ACTSI support comes in many forms, including service support provided by the Clinical Research Network (CRN), pilot project funding or seed grants, statistical support, informatics services, ethics consultations, and the use of ACTSI-funded resources and/or facilities.

Cite Submit Share ItPlease include the following citation in any publications resulting from direct or indirect Atlanta Clinical & Translational Science Institute (ACTSI) support:

"Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

KL2 Scholars should also list KL2 TR000455 and TL1 Trainees should also list TL1 TR000456.

View Citation Letter from ACTSI PI

ACTSI Patent Citation Information

The following language must be included in the text of patent applications resulting from direct or indirect Atlanta Clinical & Translational Science Institute (ACTSI) support:

"This invention was made with government support under NIH Grant No. UL1TR000454 awarded by the National Institutes of Health of the United States government. The government has certain rights in this invention."

NIH Public Access Policy

Any peer-reviewed manuscripts that arise from NIH funds, such as ACTSI support, must also be submitted to PubMed Central. This will assure continued funding of ACTSI which exists to support research efforts.

Contact

Andrew C. West, MBA, MHA

Upcoming Events

View All Events

Discovery News

Training

KL2 Scholar Studies Novel Hematopoietic Stem Cell Approach to Sickle Cell Disease Treatment

Elizabeth Stenger, MD, MSc, assistant professor, Department of Pediatrics, Emory University School of Medicine, received a K23 award for her work on improving haploidentical hematopoietic stem cell transplantation in sickle cell disease using...

Discovery

Research Resources 101: Using ACTSI's i2b2 Tool to Query Electronic Healthcare Records for Patient Study Feasibility Data-Thursday

The capabilities of Emory i2b2 will be discussed including how to query the Emory Healthcare electronic health record data for patient counts and aggregate data for grants/IRB protocols and other ways i2b2 can accelerate the pre-research process....